摘要
目的研究血浆凝血因子Ⅷ活性测定对胃癌患者静脉血栓栓塞(VTE)风险的评估价值及其医学决定水平的确定。方法用ILACLTOP一700型血液凝固仪测定凝血因子Ⅷ活性(FⅧ:A)。用ROC评价FⅧ:A的诊断性能。采用Kaplan—Meier曲线进行生存分析。结果胃癌患者组血浆FⅧ:A(123.1±34.0%)高于健康对照组(106.8±16.7%),发生VrE胃癌患者组的FⅧ:A(184.4±47.7%)高于未发生VrE胃癌患者组(113.2±16.9%),差异均有统计学意义(P〈0.05)。不同分期患者FⅧ:A水平表现为,ⅢC期〉ⅢA期和ⅢB期〉Ⅱ期(P〈0.05),Ⅱ期与对照组间差异无统计学意义(P〉0.05)。ROC分析结果显示,血浆FⅧ:A诊断胃癌患者vrE发生的临界值为125.5%时,诊断敏感性为95.2%,诊断特异性为71.0%。血浆FⅧ:A水平高于临界值对患者在90d内的vrE累计概率显著增高(Log—rankzk45.024,P=0.000)。结论胃癌患者血浆FⅧ:A显著增高,并与病程发展相关,对vrE发生风险具有评估价值。
Objective To study the value of measuring the activity of plasma coagulation factorⅧ (FⅧ :A) in the assessment of risk of venous thromboembolism (VTE) among patients with gastric carcinoma, and to establish the medicinal decision level. Methods IL ACL TOP - 700 blood coagulation analyzer was used to assay F Ⅷ :A. Receiver operating characteristic curve (ROC) was employed to analyze the diagnosis performance of FⅧ :A, and Kaplan- Meier curve was applied to implement sur- vival analysis. Results The plasma F Ⅷ : A level was higher in gastric carcinoma patients ( 123.1 ±34.0 % ) than in the healthy controls ( 106.8 ±16.7 % ), with statistically significant differences (P 〈 0.05). The plasma FⅧ : A level of gastric car- cinoma patients with VTE ( 184.4 ±47.7% ) was higher than that of gastric carcinoma patients without VTE ( 113.2 ± 16.9% ), with statistically significant differences (P〈0.05). The plasma FⅧ :A levels of patients with different stages of gas- tric carcinoma showed that stage Ⅲ C 〉ⅢA and ⅢB〉 Ⅱ (P 〈 0.05), and no statistically significant difference was found be- tween patients with stage U gastric carcinoma and the healthy controls (P〉0.05). The result of ROC analysis showed that the optimum cut- off point with FVl :A for VTE diagnosis in gastric carcinoma patients was 125.5 %, with the diagnosis sensitivity of 95.2% and the diagnosis specificity of 71.0%. The cumulative probability of VTE was increased significantly within 90 days in the patients with plasma FⅧ :A level over the cut - off value (Log - rank X2 = 45. 024, P = 0. 000). Conclusions The plasma FⅧ :A level significantly increases in patients with gastric carcinoma, moreover, it is associated with the disease progres- sion and has predictive value in the risk assessment of VTE.
出处
《实用预防医学》
CAS
2015年第8期1001-1003,共3页
Practical Preventive Medicine
基金
湖南省卫计委科研基金项目(C2009-009)
关键词
凝血因子Ⅷ
胃癌
静脉血栓栓塞
风险评价
生物标志物
Coagulation factor Ⅷ
Gastric carcinoma
Venous thromboembolism
Risk assessment
Biomarker